Mark Blaine Geyer (Mark B Geyer)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 20

Top Topics

Stem Cell Transplantation

Acute Lymphoblastic Leukemia

Top Venues

Leukemia & lymphoma

Expert review of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Yannis K Valtis, David Nemirovsky, Andriy Derkach, Saumya Sharan, Charlene Claire Kabel, Ricardo Ortiz, Meghan C Thompson, Lindsey Elizabeth Roeker, Mark Blaine Geyer
Real-world incidence and prevention of tumor lysis syndrome in chronic lymphocytic leukemia treated with venetoclax. Blood advances (2024)
Joseph G W McCarter, David Nemirovsky, Christopher A Famulare, Noushin Farnoud, Abhinita S Mohanty, Zoe S Stone-Molloy, Jordan Chervin, Brian J Ball, Zachary D Epstein-Peterson, Maria E Arcila, Aaron James Stonestrom, Andrew Dunbar, Sheng F Cai, Jacob Lowell Glass, Mark Blaine Geyer, Raajit K Rampal, Ellin Berman, Omar I Abdel-Wahab, Eytan M Stein, Martin S Tallman, Ross L Levine, Aaron D Goldberg, Elli Papaemmanuil, Yanming Zhang, Mikhail Roshal, Andriy Derkach, Wenbin Xiao
Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia. Blood advances (2023)
Rose Parisi, Emily A Cowen, Stephanie Gu, Stephen Dusza, Melissa Pulitzer, Mark Blaine Geyer, Amber C King, Alina Markova
Dermatologic adverse events in acute lymphocytic leukemia patients treated with bispecific T-cell engager blinatumomab. Leukemia & lymphoma (2023)
Pallavi Galera, Deepika Dilip, Andriy Derkach, Alexander Chan, Yanming Zhang, Sonali Persuad, Tanmay Mishera, Ying Liu, Christopher Famulare, Qi Gao, Douglas A Mata, Maria E Arcila, Mark Blaine Geyer, Eytan M Stein, Ahmet Dogan, Ross L Levine, Mikhail Roshal, Jacob Lowell Glass, Wenbin Xiao
Acute myeloid leukemia with mixed phenotype is characterized by stemness transcriptomic signatures and limited lineage plasticity. medRxiv : the preprint server for health sciences (2023)
Michael J Mauro, Timothy P Hughes, Dong-Wook Kim, Delphine Rea, Jorge E Cortes, Andreas Hochhaus, Koiji Sasaki, Massimo Breccia, Moshe Talpaz, Oliver Ottmann, Hironobu Minami, Yeow Tee Goh, Daniel J DeAngelo, Michael C Heinrich, Valle Gómez-García de Soria, Philipp le Coutre, Francois-Xavier Mahon, Jeroen J W M Janssen, Michael Deininger, Naranie Shanmuganathan, Mark Blaine Geyer, Silvia Cacciatore, Fotis Polydoros, Nithya Agrawal, Matthias Hoch, Fabian Lang
Asciminib monotherapy in patients with CML-CP without BCR::ABL1 T315I mutations treated with at least two prior TKIs: 4-year phase 1 safety and efficacy results. Leukemia (2023)
Mark Blaine Geyer, Brian C Shaffer, Bhavana Bhatnagar, Alice S Mims, Victoria Klein, Deepika Dilip, Jacob Lowell Glass, Gerard Lozanski, Hani Hassoun, Heather J Landau, Yanming Zhang, Wenbin Xiao, Mikhail Roshal, Jae H Park
Lenalidomide-associated B-cell ALL: clinical and pathologic correlates and sensitivity to lenalidomide withdrawal. Blood advances (2023)
Kitsada Wudhikarn, Amber C King, Mark Blaine Geyer, Mikhail Roshal, Yvette Bernal, Boglarka Gyurkocza, Miguel-Ángel Perales, Jae H Park
Outcomes of relapsed B-cell acute lymphoblastic leukemia after sequential treatment with blinatumomab and inotuzumab. Blood advances 6 (5) (2022)
Alison J Moskowitz, Paola Ghione, Eric D Jacobsen, Jia Ruan, Jonathan H Schatz, Sarah J Noor, Patricia L Myskowski, Santosha A Vardhana, Nivetha Ganesan, Helen Hancock, Theresa Davey, Leslie Perez, Sunyoung Ryu, Alayna Marie Santarosa, Jack Dowd, Obadi Obadi, Lauren Danielle Pomerantz, Nancy Yi, Samia Sohail, Natasha Galasso, Rachel Neuman, Brielle Liotta, William Blouin, Jeeyeon Baik, Mark Blaine Geyer, Ariela Noy, David J Straus, Priyadarshini Kumar, Ahmet Dogan, Travis J Hollmann, Esther Drill, Jürgen Rademaker, Heiko Schöder, Giorgio Ga Inghirami, David M Weinstock, Steven M Horwitz
Phase II biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas. Blood (2021)
Kitsada Wudhikarn, Jessica R Flynn, Isabelle Rivière, Mithat Gönen, Xiuyan Wang, Brigitte Senechal, Kevin J Curran, Mikhail Roshal, Peter G Maslak, Mark Blaine Geyer, Elizabeth F Halton, Claudia Diamonte, Marco L Davila, Michel Sadelain, Renier J Brentjens, Jae H Park
Interventions and outcomes of adult patients with B-ALL progressing after CD19 chimeric antigen receptor T-cell therapy. Blood 138 (7) (2021)
Maximilian Stahl, Varun Narendra, Justin Jee, Andriy Derkach, Molly Maloy, Mark Blaine Geyer, Anthony R Mato, Lindsey E Roeker, Martin S Tallman, Gunjan L Shah, Anthony Daniyan, Aaron D Goldberg
Neutropenia in adult acute myeloid leukemia patients represents a powerful risk factor for COVID-19 related mortality. Leukemia & lymphoma 62 (8) (2021)
Ryan J Daley, Sridevi Rajeeve, Charlene C Kabel, Jeremy J Pappacena, Sarah E Stump, Jessica A Lavery, Martin S Tallman, Mark Blaine Geyer, Jae H Park
Tolerability and toxicity of pegaspargase in adults 40 years and older with acute lymphoblastic leukemia. Leukemia & lymphoma 62 (1) (2020)
Charles Gaulin, Angela Chan, Andriy Derkach, Jae H Park, Simon Mantha, Mark Blaine Geyer, Martin S Tallman
Hypofibrinogenemia and disseminated intravascular coagulation rarely complicate treatment-naïve acute lymphoblastic leukemia. Leukemia & lymphoma 61 (10) (2020)
Mark Blaine Geyer, Omar Abdel-Wahab, Martin S Tallman
BRAF in the cross-hairs. Expert review of hematology 12 (3) (2019)
Eric L Smith, Sham Mailankody, Mette Staehr, Xiuyan Wang, Brigitte Senechal, Terence J Purdon, Anthony F Daniyan, Mark Blaine Geyer, Aaron D Goldberg, Elena Mead, Bianca D Santomasso, Jonathan Landa, Andreas Rimner, Isabelle Riviere, Ola Landgren, Renier J Brentjens
BCMA-Targeted CAR T-cell Therapy plus Radiotherapy for the Treatment of Refractory Myeloma Reveals Potential Synergy. Cancer immunology research 7 (7) (2019)
Mark Blaine Geyer
First CAR to Pass the Road Test: Tisagenlecleucel's Drive to FDA Approval. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (4) (2018)
Jessica Hochberg, Stacey Zahler, Mark Blaine Geyer, Nan Chen, Jennifer Krajewski, Lauren Harrison, Olga Militano, M Fevzi Ozkaynak, Alexandra C Cheerva, Julie Talano, Theodore B Moore, Alfred P Gillio, Mark C Walters, Lee Ann Baxter-Lowe, Carl Hamby, Mitchell S Cairo
The safety and efficacy of clofarabine in combination with high-dose cytarabine and total body irradiation myeloablative conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults (CAYA) with poor-risk acute leukemia. Bone marrow transplantation 54 (2) (2018)
Mark Blaine Geyer, Martin S Tallman
Digging deeper in relapsed acute lymphoblastic leukemia: impact of MRD status on outcome in second remission. Leukemia & lymphoma 59 (2) (2017)
Mark Blaine Geyer, Shwetha H Manjunath, Andrew G Evans, Jae H Park, Marco L Davila, Corey S Cutler, Xiuyan Wang, Yongzeng Wang, Brigitte Senechal, Isabelle Rivière, Michel Sadelain, Jane L Liesveld, Renier J Brentjens
Concurrent therapy of chronic lymphocytic leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia utilizing CD19-targeted CAR T-cells. Leukemia & lymphoma 59 (7) (2017)
Mark Blaine Geyer, Meier Hsu, Sean M Devlin, Martin S Tallman, Dan Douer, Jae H Park
Overall survival among older US adults with ALL remains low despite modest improvement since 1980: SEER analysis. Blood 129 (13) (2017)
Jae H Park, Mark Blaine Geyer, Renier J Brentjens
CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date. Blood 127 (26) (2016)